| 2022-09-24 |
复牌提示：
2022-09-23 14:01:12 停牌，复牌日期 2023-06-07 16:45:00
|
| 2022-08-16 |
详情>>
股本变动：
变动后总股本13391.47万股
|
| 2022-08-16 |
详情>>
业绩披露：
2022年年报每股收益4.12元,归母净利润5.01亿元,同比去年增长-1.41%
|
| 2022-02-28 |
详情>>
业绩披露：
2022年三季报(累计)每股收益3.26元,归母净利润3.96亿元,同比去年增长4.16%
|
| 2022-02-28 |
财报披露：
美东时间 2022-02-28 盘后发布财报
|
| 2021-12-03 |
详情>>
业绩披露：
2022年中报每股收益2.15元,归母净利润2.62亿元,同比去年增长-0.68%
|
| 2021-10-29 |
股东大会：
将于2021-12-07召开股东大会
会议内容 ▼▲
- 1.To ratify the re-appointment of KPMG Huazhen LLP as auditors of the Company for the financial year ending March 31, 2022 and to authorize any duly formed committee of the Board of Directors to fix the remuneration of the auditors.
2.To re-elect the following directors, each of whom retires by rotation pursuant to the Company’s Articles of Association:
a.Ms. Jennifer J. Weng (Class C director of the Company);
b.Mr. Ping Xu (Class C director of the Company);
c.Mr. Jacky Cheng (Class C director of the Company).
3.To transact such other business as may properly come before the meeting or any adjournment or adjournments thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-08-30 |
详情>>
业绩披露：
2022年一季报每股收益1.12元,归母净利润1.36亿元,同比去年增长2.95%
|
| 2021-07-29 |
详情>>
业绩披露：
2019年年报每股收益2.40元,归母净利润2.91亿元,同比去年增长22.79%
|
| 2021-07-29 |
详情>>
业绩披露：
2021年年报每股收益4.18元,归母净利润5.08亿元,同比去年增长7.97%
|
| 2021-02-24 |
详情>>
业绩披露：
2021年三季报(累计)每股收益3.13元,归母净利润3.81亿元,同比去年增长1.82%
|
| 2020-12-08 |
详情>>
业绩披露：
2021年中报每股收益2.17元,归母净利润2.64亿元,同比去年增长15.41%
|
| 2020-10-28 |
股东大会：
将于2020-12-07召开股东大会
会议内容 ▼▲
- 1.To ratify the re-appointment of KPMG Huazhen LLP as auditors of the Company for the financial year ending March 31, 2021 and to authorize any duly formed committee of the Board of Directors to fix the remuneration of the auditors.
2.To re-elect the following directors, each of whom retires by rotation pursuant to the Company’s Articles of Association:
a.Ms. Ting Zheng (Class B director of the Company);
b.Dr. Ken Lu (Class B director of the Company);
c. Mr. Jack Chow (Class B director of the Company).
3.To transact such other business as may properly come before the meeting or any adjournment or adjournments thereof.
|
| 2020-08-24 |
详情>>
业绩披露：
2021年一季报每股收益1.09元,归母净利润1.33亿元,同比去年增长22.30%
|
| 2020-07-29 |
详情>>
业绩披露：
2020年年报每股收益3.87元,归母净利润4.71亿元,同比去年增长61.69%
|
| 2019-10-30 |
股东大会：
将于2019-12-05召开股东大会
会议内容 ▼▲
- 1.To ratify the re-appointment of KPMG Huazhen LLP as auditors of the Company for the financial year ending March 31, 2020 and to authorize any duly formed committee of the Board of Directors to fix the remuneration of the auditors.
2.To re-elect the following directors, each of whom retires by rotation pursuant to the Company’s Articles of Association:
a.Mr. Albert Chen (Class A director of the Company);
b.Mr. Mark D. Chen (Class A director of the Company).
3.To transact such other business as may properly come before the meeting or any adjournment or adjournments thereof.
|
| 2018-10-30 |
股东大会：
将于2018-12-05召开股东大会
会议内容 ▼▲
- 1.To ratify the re-appointment of KPMG Huazhen LLP as auditors of the Company for the financial year ending March 31, 2019 and to authorize any duly formed committee of the directors to fix the remuneration of the auditors.
2.To re-elect the following directors, each of whom retires by rotation pursuant to the Company’s Articles of Association:
a.Ms. Jennifer J. Weng (Class C director of the Company);
b.Mr. Ping Xu (Class C director of the Company).
3.To transact such other business as may properly come before the meeting or any adjournment or adjournments thereof.
|
| 2018-06-26 |
除权日：
美东时间 2018-07-27 每股派息0.08美元
|
| 2018-02-28 |
股东大会：
将于2018-03-16召开股东大会
会议内容 ▼▲
- 1.THAT:
1.1subject to the approval of the Registrar of Companies in the Cayman Islands, the English name of the Company be changed from “China Cord Blood Corporation” to “Global Cord Blood Corporation” and the Chinese name “國際臍帶血庫企業集團” be adopted as the dual foreign name in Chinese of the Company to replace the existing Chinese name of the Company “中國臍帶血庫企業集團” which has been used by the Company for identification purposes only (the “Proposed Change of Company Name”);
1.2subject to the passing of resolution numbered (i) above and the Proposed Change of Company Name taking effect, the memorandum of association (the “Memorandum”) and the articles of association of the Company (the “Articles”) be and are hereby amended by deleting the name “China Cord Blood Corporation” and replacing therewith the name “Global Cord Blood Corporation 國際臍帶血庫企業集團” in the Memorandum and the Articles;
1.3any director or the secretary of the Company be and each of them is hereby authorized to do all such acts and things and execute all documents and make all arrangements as he/she/they consider necessary or expedient to give effect to the foregoing resolutions and to attend to any necessary registration and/or filing for and on behalf of the Company.
|
| 2017-10-31 |
股东大会：
将于2017-12-07召开股东大会
会议内容 ▼▲
- 1.To ratify the re-appointment of KPMG Huazhen LLP as auditors of the Company for the financial year ending March 31, 2018 and to authorize any duly formed committee of the directors to fix the remuneration of the auditors.
2.To re-elect the following directors, each of whom retires by rotation pursuant to the Company’s Articles of Association:
a.Ms. Ting Zheng (Class B director of the Company);
b.Dr. Ken Lu (Class B director of the Company).
3.To transact such other business as may properly come before the meeting or any adjournment or adjournments thereof.
|
| 2016-11-02 |
股东大会：
将于2016-12-09召开股东大会
会议内容 ▼▲
- 1.To ratify the re-appointment of KPMG Huazhen LLP as auditors of the Company for the financial year ending March 31, 2017 and to authorize any duly formed committee of the directors to fix the remuneration of the auditors.
2.To re-elect the following directors, each of whom retires by rotation pursuant to the Company’s Articles of Association:
a.Mr. Albert Chen (Class A director of the Company);
b.Mr. Mark D. Chen (Class A director of the Company).
3.To transact such other business as may properly come before the meeting or any adjournment or adjournments thereof.
|
| 2015-11-02 |
股东大会：
将于2015-12-10召开股东大会
会议内容 ▼▲
- 1.To ratify the re-appointment of KPMG as auditors of the Company for the financial year ending March 31, 2016 and to authorize any duly formed committee of the directors to fix the remuneration of the auditors.
2.To re-elect the following directors, each of whom retires by rotation pursuant to the Company’s Articles of Association:
a.Mr. Yuen Kam (Class C director of the Company);
b.Ms. Jennifer J. Weng (Class C director of the Company).
3.To transact such other business as may properly come before the meeting or any adjournment or adjournments thereof.
|
| 2014-11-03 |
股东大会：
将于2014-12-11召开股东大会
会议内容 ▼▲
- 1.To ratify the re-appointment of KPMG as auditors of the Company for the financial year ending March 31, 2015 and to authorize any duly formed committee of the directors to fix the remuneration of the auditors.
2.To re-elect the following directors, each of whom retires by rotation pursuant to the Company’s Articles of Association:
a.Ms. Ting Zheng;
b.Dr. Ken Lu.
3.To transact such other business as may properly come before the meeting or any adjournment or adjournments thereof.
|
| 2013-11-08 |
股东大会：
将于2013-12-16召开股东大会
会议内容 ▼▲
- 1. To ratify the re-appointment of KPMG as auditors of the Company for the financial year ending March 31, 2014 and to authorize any duly formed committee of the directors to fix the remuneration of the auditors.
2. To re-elect the following Directors, each of whom retires by rotation pursuant to the Company’s Articles of Association:
a. Mr. Albert Chen
b. Mr. Mark Chen
3. To transact such other business as may properly come before the meeting or any adjournment or adjournments thereof.
|